Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Çem Akin, MD, a specialist in allergy and immunology at the University of Michigan, about various treatment options for systemic mastocytosis.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Federico Stella, MD, on the controversial practice of severely restricting the diets of patients who have just undergone stem cell transplants. Read the full story here: Italian Hematologist Urges End to ‘Useless’ Restrictive Diets After Stem Cell Transplants
According to the National Organization for Rare Disorders (NORD), which of the following statements about rare disease facts and statistics are correct? Select one of the options for each question, then submit your answers to see your score and the average score for everyone who has taken the quiz. Read more about NORD. Reference Rare…
Which of the following statements about US Food and Drug Administration (FDA) support for rare diseases are correct? Select one of the options for each question, then submit your answers to see your score and the average score for everyone who has taken the quiz. Read more about rare diseases at the FDA. Reference Rare…
Which of the statements below about experimental therapies for systemic mastocytosis is incorrect? Select a response, then submit your answer to see your score and the score for everyone who has taken the quiz. Read more about systemic mastocytosis experimental therapies.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Abigail Jenkins, president and CEO of Gamida Cell, on the company’s development of omidubicel as an alternative to umbilical cord blood in stem cell transplants for myelofibrosis and other diseases. Read the full story here: Omidubicel Shows Promise as Replacement for Umbilical Cord Blood in Stem…
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Philip J. Brooks, PhD, acting director of the Division of Rare Diseases Research Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences.
Which of the following comorbidities are not associated with systemic mastocytosis (SM)? Submit your answer to see your score and the average score for everyone who has taken the quiz. Read more about systemic mastocytosis comorbidities.
Which of the statements below about systemic mastocytosis (SM) guidelines are correct? Select a response for each question, then submit your answers to see your score and the average score for everyone who has taken the quiz. Read more about SM guidelines.
Which of the statements below about the diagnosis of systemic mastocytosis (SM) is correct? Select one of the options for the question, then submit your answer to see your score and the average score for everyone who has taken the quiz. Read more about systemic mastocytosis diagnosis.
Please login or register first to view this content.
